Effects/NNS
of/IN
prostaglandin/NN
E2/NN
on/IN
Th0-type/JJ
human/JJ
T/NN
cell/NN
clones/NNS
:/:
modulation/NN
of/IN
functions/NNS
of/IN
nuclear/JJ
proteins/NNS
involved/VBN
in/IN
cytokine/NN
production/NN
./.

The/DT
effects/NNS
of/IN
prostaglandin/NN
E2/NN
(/(
PGE2/NN
)/)
on/IN
cytokine/NN
production/NN
and/CC
proliferation/NN
of/IN
the/DT
CD4+/JJ
human/JJ
helper/NN
T/NN
cell/NN
clone/NN
SP-B21/NN
were/VBD
investigated/VBN
./.
=====
In/IN
cells/NNS
stimulated/VBN
with/IN
anti-CD3/JJ
mAb/NN
,/,
PGE2/NN
inhibited/VBD
cell/NN
proliferation/NN
and/CC
the/DT
production/NN
of/IN
all/PDT
the/DT
cytokines/NNS
examined/VBN
./.
=====
Addition/NN
of/IN
rIL-2/NN
fully/RB
restored/VBD
the/DT
proliferative/JJ
response/NN
and/CC
partially/RB
restored/VBD
the/DT
production/NN
of/IN
IL-4/NN
and/CC
IL-5/NN
,/,
but/CC
not/RB
that/DT
of/IN
other/JJ
cytokines/NNS
./.
=====
In/IN
contrast/NN
,/,
in/IN
cells/NNS
stimulated/VBN
with/IN
phorbol/NN
myristate/NN
acetate/NN
(/(
PMA/NN
)/)
/A23187/NN
,/,
PGE2/NN
enhanced/VBD
the/DT
production/NN
of/IN
IL-4/NN
and/CC
IL-5/NN
,/,
and/CC
only/RB
partially/RB
inhibited/VBD
the/DT
production/NN
of/IN
other/JJ
cytokines/NNS
./.
=====
Therefore/RB
,/,
the/DT
effects/NNS
of/IN
PGE2/NN
vary/VBP
depending/VBG
on/IN
the/DT
mode/NN
of/IN
T/NN
cell/NN
activation/NN
,/,
and/CC
the/DT
IL-4/NN
and/CC
IL-5/NN
are/VBP
regulated/VBN
differently/RB
from/IN
other/JJ
cytokines/NNS
./.
=====
In/IN
a/DT
mobility/NN
shift/NN
assay/NN
,/,
only/RB
the/DT
NF-kappa/NN
B/NN
(/(
p50/p50/NN
)/)
homodimer/NN
was/VBD
observed/VBN
in/IN
a/DT
complex/NN
formed/VBN
with/IN
the/DT
kappa/NN
B/NN
sequence/NN
in/IN
unstimulated/JJ
SP-B21/NN
cells/NNS
./.
=====
When/WRB
cells/NNS
were/VBD
stimulated/VBN
with/IN
anti-CD3/JJ
mAb/NN
or/CC
PMA/A23187/NN
,/,
a/DT
complex/NN
formation/NN
of/IN
NF-kappa/NN
B/NN
(/(
p50/p65/NN
)/)
heterodimer/NN
with/IN
the/DT
kappa/NN
B/NN
sequence/NN
was/VBD
induced/VBN
./.
=====
Interestingly/RB
,/,
PGE2/NN
or/CC
di-butyryl/NN
(/(
Bt2/NN
)/)
cAMP/NN
abolished/VBD
the/DT
binding/NN
of/IN
NF-kappa/NN
B/NN
(/(
p50/p65/NN
)/)
heterodimer/NN
to/TO
the/DT
kappa/NN
B/NN
sequence/NN
in/IN
cells/NNS
stimulated/VBN
with/IN
anti-CD3/JJ
mAb/NN
but/CC
not/RB
with/IN
PMA/A23187/NN
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
the/DT
target/NN
of/IN
PGE2/NN
action/NN
is/VBZ
a/DT
component/NN
in/IN
the/DT
signal/NN
transduction/NN
pathway/NN
leading/VBG
to/TO
the/DT
activation/NN
of/IN
protein/NN
kinase/NN
C/NN
./.
=====
However/RB
,/,
the/DT
inhibition/NN
of/IN
the/DT
T/NN
cell/NN
activation/NN
signals/NNS
by/IN
PGE2/NN
is/VBZ
selective/JJ
./.
=====
PGE2/NN
enhanced/VBD
the/DT
complex/NN
formation/NN
with/IN
NF-AT/NN
,/,
AP-1/NN
and/CC
CLE0/NN
sequences/NNS
when/WRB
the/DT
cells/NNS
were/VBD
activated/VBN
by/IN
either/CC
anti-CD3/JJ
mAb/NN
or/CC
PMA/A23187/NN
stimulation/NN
./.
=====
It/PRP
seems/VBZ
therefore/RB
that/IN
PGE2/NN
,/,
by/IN
elevating/VBG
cAMP/NN
levels/NNS
,/,
interferes/VBZ
with/IN
the/DT
activation/NN
pathway/NN
for/IN
NF-kappa/NN
B/NN
but/CC
not/RB
for/IN
NF-AT/NN
,/,
AP-1/NN
or/CC
CLE0/NN
binding/NN
protein/NN
./.